Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open‐label, phase 2 trial
Ulys, Albertas, Jankevicus, Feliksas, Jievaltas, Mindaugas, Venckus, Raimundas, Auskalnis, Stasys, Kardelis, Zygimantas, Barisiene, Marija, MacLean, Carol M., Os, Steve, Larsen, Finn
Published in The Prostate (01.05.2024)
Published in The Prostate (01.05.2024)
Get full text
Journal Article